JENNIFER LEIGH MCQUADE to Antibodies, Monoclonal
This is a "connection" page, showing publications JENNIFER LEIGH MCQUADE has written about Antibodies, Monoclonal.
Connection Strength
0.100
-
Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy. J Immunother Cancer. 2017; 5:8.
Score: 0.058
-
Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature. 2022 11; 611(7934):155-160.
Score: 0.021
-
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series. Melanoma Res. 2022 12 01; 32(6):451-459.
Score: 0.021